Identification and natural antibiotic susceptibility of Morganella morganii

Diagnostic Microbiology and Infectious Disease

Volumn 30, Issue 3, 1998, Pages 153-165

  Stock, Ingo ^a   Wiedemann, Bernd ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AZTREONAM; CARBAPENEM DERIVATIVE; CEFPODOXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GLYCOPEPTIDE; LINCOSAMIDE DERIVATIVE; MACROLIDE; MEZLOCILLIN; MONOBACTAM DERIVATIVE; NITROFURANTOIN; ORNITHINE DECARBOXYLASE; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFAMETHOXAZOLE; TETRACYCLINE DERIVATIVE; TICARCILLIN; TREHALOSE; UNINDEXED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; ENZYME ACTIVITY; FERMENTATION; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TAXONOMY;

EID: 0032031916     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00243-5     Document Type: Article

References (11)

1. Brenner DJ, Farmer JJ, Fanning GR, Steigerwalt AG, Klykken P, Wathen HG, Hickman FW, Ewing WH. Deoxyribonucleic acid relatedness of Proteus and Providencia species. Int J Syst Bacteriol. 28:1993;269-282.
2. Cornelis G, Van Bouchaute M, Wauters G. Plasmid-encoded lysine decarboxylation in Proteus morganii. J Clin Microbiol. 14:1981;365-369.
3. Farmer JJ III. Enterobacteriaceae introduction and identification . Murray P, Baron E, Pfaller M, Tenover F, Yolken R. Manual of Clinical Microbiology. 1995;438-449 American Society of Microbiology, New York.
4. Farmer JJ III, Davis BR, Hickmann-Brenner FW, et al. Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol. 21:1985;46-76.
5. Hickman FW, Farmer JJ III, Steigerwalt AG, Brenner DJ. Unusual groups of Morganella ("Proteus") morganii isolated from clinical specimens lysine-positive and ornithine-negative biogroups . J Clin Microbiol. 12:1980;88-94.
6. Janda JM, Abbott SL, Khashie S, Robin T. Biochemical investigation of biogroups and subspecies of Morganella morganii. J Clin Microbiol. 1:1996;108-113.
7. Jensen KT, Frederiksen W, Hickman-Brenner FW, Steigerwalt AG, Riddle CF, Brenner DJ. Recognition of Morganella subspecies, with proposal of Morganella morganii subsp. morganii subsp. nov. and Morganella morganii subsp. sibonii subsp. nov. Int J Syst Bacteriol. 42:1992;613-620.
8. Livermore DM. Determinants of the activity of β-lactamase inhibitor combinations. J Antimicrob Chem. 31:(suppl A):1993;S9-S21.
9. Livermore DM, Chen HJ. Comparative in-vitro activity of biapenem against enterobacteria with β-lactamase-mediated antibiotic resistance. J Antimicrob Chem. 33:1994;453-464.
10. Penner JL. Genus XIII Morganella Fulton 1943. Krieg NR, Holt JG. Bergey's Manual of Systematic Bacteriology. 1984;497 Williams and Wilkins, London.
11. Siboni K. Correlation of the characters fermentation of trehalose, nontransmissible resistance to tetracycline, and relatively long flagellar wavelength in Proteus morganii. Acta Pathol Microbiol Scand Sect. B84:1976;421-427.